XML 18 R8.htm IDEA: XBRL DOCUMENT v3.22.1
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
$ in Thousands
Common Stock [Member]
Voting [Member]
Additional Paid-In Capital [Member]
Cost of Repurchased Common Stock [Member]
Accumulated Other Comprehensive Income (Loss) [Member]
Accumulated Earnings [Member]
Non-Controlling Interest [Member]
Total
Beginning balance at Dec. 31, 2020 $ 195 $ 102,423 $ (10,191) $ (2,635) $ 23,645 $ 4,050 $ 117,487
Beginning balance (in shares) at Dec. 31, 2020             19,133,794
Unrealized loss on MSA investments, net of tax 0 0 0 (452) 0 0 $ (452)
Unrealized gain on derivative instruments, net of tax 0 0 0 2,448 0 0 2,448
Foreign currency translation, net of tax 0 0 0 159 0 159 318
Stock compensation expense 0 1,498 0 0 0 0 1,498
Exercise of options $ 1 424 0 0 0 0 425
Exercise of options (in shares) 44,357            
Redemption of options $ 0 (1,466) 0 0 0 0 (1,466)
Cost of repurchased common stock 0 0 $ (5,733) 0 0 0 (5,733)
Cost of repurchased common stock (in shares)     (119,031)        
Dividends 0 0 $ 0 0 (1,071) 0 (1,071)
Net income 0 0 0 0 11,783 (255) 11,528
Ending balance at Mar. 31, 2021 196 102,879 (15,924) (480) 34,357 3,954 $ 124,982
Ending balance (in shares) at Mar. 31, 2021             19,059,120
Beginning balance at Dec. 31, 2020 195 102,423 (10,191) (2,635) 23,645 4,050 $ 117,487
Beginning balance (in shares) at Dec. 31, 2020             19,133,794
Ending balance at Dec. 31, 2021 197 108,811 (48,869) (195) 71,460 2,312 $ 133,716
Ending balance (in shares) at Dec. 31, 2021             18,395,476
Unrealized loss on MSA investments, net of tax 0 0 0 (1,126) 0 0 $ (1,126)
Unrealized gain on derivative instruments, net of tax             0
Foreign currency translation, net of tax 0 0 0 (5) 0 (2) (7)
Stock compensation expense 0 1,159 0 0 0 0 1,159
Exercise of options $ 0 245 0 0 0 0 245
Exercise of options (in shares) 25,166            
Performance restricted stock units issuance $ 1 (1) 0 0 0 0 0
Performance restricted stock units issuance (in shares) 103,843            
Performance restricted stock units redeemed $ 0 (1,141) 0 0 0 0 (1,141)
Performance restricted stock units redeemed (in shares) (34,087)            
Cost of repurchased common stock $ 0 0 $ (10,622) 0 0 0 $ (10,622)
Cost of repurchased common stock (in shares)     (310,224)       (310,224)
Dividends 0 0 $ 0 0 (1,131) 0 $ (1,131)
Net income 0 0 0 0 10,998 (227) 10,771
Ending balance at Mar. 31, 2022 $ 198 $ 109,073 $ (59,491) $ (1,326) $ 81,327 $ 2,083 $ 131,864
Ending balance (in shares) at Mar. 31, 2022             18,180,174